IGS GeboJagema
Bart Cauberghe is a seasoned professional with extensive experience in investment and board roles across various industries, particularly in healthcare and technology. As the Managing Partner and co-founder of Smile Invest since June 2017, Cauberghe has been instrumental in managing over €500 million in assets, focusing on innovative companies in technology, healthcare, and sustainability. Additional board memberships include positions at MedEnvision, Cargo Floor B.V., IGS GeboJagema, 4ITEGO, Hospidex, Oldelft Ultrasound, SmartSD, and Microflor, where strategic oversight and governance in rapidly evolving markets have been key contributions. With an educational background that includes a PhD in Applied Sciences from Vrije Universiteit Brussel and executive programs from Harvard Business School and INSEAD, Cauberghe combines technical expertise with business acumen to drive growth and innovation.
This person is not in any teams
This person is not in any offices
IGS GeboJagema
Our work touches billions of people’s lives every day From glasses and contact lenses to asthma inhalers, insulin pens and blood diagnostic devices. Our work can be found in products where extreme precision is vital. We believe that constantly pushing the envelope and delivering work of the highest possible quality is the key to making people all over the world healthier and happier. With a drive for innovative solutions and unrivalled attention to detail and precision, we design, manufacture, qualify and maintain injection moulds for the optical, healthcare and packaging industries. IGS GEBOJAGEMA delivers the highest level of validated precision and high-precision moulds and components, single mould projects and series of moulds that are part of a multi-assembled device and multiple sets of repeat tooling, on time and in specification to any designated global location.